|
|
Market Analysis Reports of Verinurad
|
Hyperuricemia - Pipeline Review, H2 2020 Hyperuricemia - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperuricemia - Pipeline Review, H2 2020, provides an overview of the Hyperuricemia (Metabolic Disorders) pipeline ...
Hyperuricemia (Metabolic Disorder) - Drugs In Development, 2021 Hyperuricemia (Metabolic Disorder) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperuricemia - Drugs In Development, 2021, provides an overview of the Hyperuricemia (Metabolic ...
Hyperuricemia - Pipeline Review, H1 2020 Hyperuricemia - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperuricemia - Pipeline Review, H1 2020, provides an overview of the Hyperuricemia (Metabolic Disorders) pipeline ...
Chronic Kidney Disease - Pipeline Review, H1 2017 Chronic Kidney Disease - Pipeline Review, H1 2017 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease - Pipeline Review, H1 2017, provides an overview of the Chronic Kidney Disease (Genito ...
Chronic Kidney Disease (CKD) – Pipeline Insight, 2020 ... Products AZD5718 MEDI8367 efepoetin alfa Verinurad Empagliflozin DDO-3055 KBP-5074 ...
Gout - Pipeline Insight, 2021 ... Products SEL 212 URC 102 Verinurad AR882 FYU-981
|
|
|
|